Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 17, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Takeda Launches Narcolepsy Drug ORZEYFUL in Japan and China, U.S. Launch Planned
Life Sciences Times
-
October 15, 2026
Pharma
Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment
Life Sciences Times
-
October 14, 2026
Pharma
Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027
Life Sciences Times
-
October 13, 2026
Pharma
Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026
Life Sciences Times
-
October 13, 2026
Pharma
Scholar Rock Resubmits European Application for Spinal Muscular Atrophy Treatment
Life Sciences Times
-
October 8, 2026
Pharma
FDA Approves Takeda’s ORZEYFUL for Narcolepsy Type 1
Life Sciences Times
-
August 6, 2026
0
Pharma
Amylyx Reports $43.4 Million Q2 Loss as Phase 3 Avexitide Data Near
Life Sciences Times
-
August 6, 2026
0
Pharma
Ono Pharma, Mediar Therapeutics Partner on Antibody Drugs for Fibro-inflammatory Diseases
Life Sciences Times
-
August 6, 2026
0
Pharma
Ironwood Raises 2026 Outlook as Q2 Revenue, Profit Climb
Life Sciences Times
-
August 6, 2026
0
Pharma
Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million
Life Sciences Times
-
August 3, 2026
0
Pharma
Meitheal Pharmaceuticals Wins FDA Approval for Garzulys Insulin Biosimilar
Life Sciences Times
-
July 31, 2026
0
Pharma
Sumitomo Pharma’s Enzomenib Receives FDA Orphan Drug Designation for Acute Lymphoblastic Leukemia
Life Sciences Times
-
July 30, 2026
0
Pharma
Alnylam Reports 74% Revenue Growth in Second Quarter, Lowers 2026 TTR Outlook
Life Sciences Times
-
July 30, 2026
0
People on the Move
Alkermes Reports $496 Million in Second-Quarter Revenue, Names Blair Jackson as Next CEO
Life Sciences Times
-
July 28, 2026
0
Pharma
FDA Approves Otsuka’s Simtriyo for ADHD in Adults and Children
Life Sciences Times
-
July 27, 2026
0
Pharma
AstraZeneca H1 Revenue Rises 9% as Oncology and Rare Disease Sales Drive Growth
Life Sciences Times
-
July 27, 2026
0
Pharma
Lantern Pharma Receives Patent Allowance for Biomarker-Guided Use of LP-184 in Solid Tumors
Life Sciences Times
-
July 23, 2026
0
1
...
3
4
5
...
101
Page 4 of 101
Most Read
Perceptive Discovery Expands Radiopharmaceutical Research Capabilities in Massachusetts and UK
October 16, 2026
Boston-Based Clasp Launches Healthcare Job Marketplace Offering Student Loan Repayment Benefits
October 16, 2026
Ironwood Pharmaceuticals Names Tammi Gaskins CEO as Tom McCourt Announces Retirement
October 16, 2026
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
October 16, 2026